The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Nuvo Pharmaceuticals Inc

TSX: NRI
Delayed quote

$7.20

Today's change+0.05 +0.70%
Updated August 23 3:59 PM EDT. Delayed by at least 15 minutes.
 

Nuvo Pharmaceuticals Inc

TSX: NRI
Delayed quote

$7.20

Today's change+0.05 +0.70%
Updated August 23 3:59 PM EDT. Delayed by at least 15 minutes.

Nuvo Pharmaceuticals Inc up $0.05

Nuvo Pharmaceuticals Inc closed up Tuesday by $0.05 or 0.70% to $7.20. Over the last five days, shares have gained 4.35% and 38.20% year to date. Shares have outperformed the S&P TSX by 27.30% during the last year.

Key company metrics

  • Trailing P/E24.11×
  • P/E 1 year forward9.41×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS$0.30
Updated August 23 3:59 PM EDT. Delayed by at least 15 minutes.

Latest Company News

View more News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue8886
Total other revenue--------
Total revenue8886
Gross profit5553
Total cost of revenue3333
Total operating expense6587
Selling / general / administrative2233
Research & development0022
Depreciation / amortization0000
Interest expense (income), net operating0--00
Unusual expense (income)----00
Other operating expenses, total--------
Operating income220-2
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets0--0--
Other--------
Income before tax220-1
Income after tax220-1
Income tax, total0000
Net income2-10-1
Total adjustments to net income--------
Net income before extra. items220-1
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items220-1
Inc. avail. to common incl. extra. items2-10-1
Diluted net income2-10-1
Dilution adjustment0------
Diluted weighted average shares12111111
Diluted EPS excluding extraordinary itemsvalue per share0.210.170.03-0.11
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share0.210.170.03-0.11